(XTLB) Xtl Biopharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xtl Biopharmaceuticals | (XTLB) share price targets
Complete technical analysis of Xtl Biopharmaceuticals (XTLB) by charts plus indicators, forecast predictions and share price targets for Xtl Biopharmaceuticals (XTLB)
Xtl Biopharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-09 View latest technical analysis
10 day averaged volume of Xtl Biopharmaceuticals is 4490
Date | Daily Closing Price | Open | High | Low | Volume |
09 Tue Jul 2024 | 2.30 | 2.30 | 2.30 | 2.30 | 0.69 times |
08 Mon Jul 2024 | 2.30 | 2.26 | 2.30 | 2.26 | 0.624 times |
05 Fri Jul 2024 | 2.30 | 2.29 | 2.30 | 2.21 | 3.118 times |
03 Wed Jul 2024 | 2.30 | 2.26 | 2.30 | 2.21 | 1.604 times |
03 Wed Jul 2024 | 2.30 | 2.26 | 2.30 | 2.21 | 1.604 times |
02 Tue Jul 2024 | 2.27 | 2.29 | 2.29 | 2.18 | 0.824 times |
01 Mon Jul 2024 | 2.16 | 2.39 | 2.39 | 2.16 | 0.423 times |
28 Fri Jun 2024 | 2.43 | 2.24 | 2.43 | 2.24 | 1.269 times |
27 Thu Jun 2024 | 2.25 | 2.09 | 2.25 | 2.08 | 0.245 times |
26 Wed Jun 2024 | 2.17 | 2.17 | 2.17 | 2.17 | 0.156 times |
My analysis of stock is bullish for shortterm, and stock might move up till 2.4 or till 2.5. Use a stoploss of 2.28 and if this stock hits its stoploss, then it can fall down till 2.17
Share price targets for Xtl Biopharmaceuticals (XTLB)
Target Type | Value |
Downside Target | 0.85 |
Downside Target | 1.85 |
Downside Target | 2.08 |
Downside Target | 2.16 |
Downside Target | 2.21 |
Downside Target | 2.26 |
Upside Target | 2.35 |
Upside Target | 2.43 |
Upside Target | 2.81 |
Upside Target | 3.15 |
Upside Target | 3.48 |
Upside Target | 4.99 |
Intraday share price targets for Xtl Biopharmaceuticals (XTLB)
Target Type | Value |
Downside Intraday Target | 2.27 |
Downside Intraday Target | 2.25 |
Upside Intraday Target | 2.31 |
Upside Intraday Target | 2.33 |
Downside Intraday Target | 2.29 |
Weekly technical analysis of Xtl Biopharmaceuticals (XTLB)
Date | Weekly Closing Price | Open | High | Low | Volume |
09 Tue Jul 2024 | 2.30 | 2.26 | 2.30 | 2.26 | 0.278 times |
05 Fri Jul 2024 | 2.30 | 2.26 | 2.30 | 2.21 | 1.656 times |
03 Wed Jul 2024 | 2.30 | 2.39 | 2.39 | 2.16 | 1.267 times |
28 Fri Jun 2024 | 2.43 | 2.31 | 2.43 | 2.08 | 0.122 times |
21 Fri Jun 2024 | 2.24 | 2.55 | 2.81 | 2.16 | 0.444 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Xtl Biopharmaceuticals (XTLB)
Date | Monthly Closing Price | Open | High | Low | Volume |
09 Tue Jul 2024 | 2.30 | 2.39 | 2.39 | 2.16 | 0.07 times |
28 Fri Jun 2024 | 2.43 | 2.57 | 2.81 | 1.85 | 2.184 times |
31 Fri May 2024 | 2.64 | 2.53 | 3.15 | 2.10 | 0.127 times |
30 Tue Apr 2024 | 2.59 | 2.75 | 3.48 | 2.35 | 0.046 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xtl Biopharmaceuticals (XTLB)
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Xtl Biopharmaceuticals in short term but the buy signal is initial and weak.
Xtl Biopharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Xtl Biopharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Xtl Biopharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.3 and Xtl Biopharmaceuticals (XTLB) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Xtl Biopharmaceuticals in short term but the buy signal is initial and weak.
Xtl Biopharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Xtl Biopharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Xtl Biopharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.3 and Xtl Biopharmaceuticals (XTLB) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.